Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions

JAMA Internal Medicine - United States
doi 10.1001/jamainternmed.2015.6102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Fibroblast Growth Factor 23 and Cardiovascular Disease in Patients With Chronic Kidney Disease

Renal Replacement Therapy
2018English

REPRINT Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease

Hypertension
Internal Medicine
2006English

Cardiovascular Risks in Chronic Kidney Disease Pediatric Patients (Review)

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

16. The Control of Cardiovascular Diseases of the Patients With Chronic Kidney Disease

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Cinacalcet in Patients With Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2013English

Managing Cardiovascular Risk in People With Chronic Kidney Disease: A Review of the Evidence From Randomized Controlled Trials

Therapeutic Advances in Chronic Disease
Medicine
2011English

Novel Combined Management Approaches to Patients With Diabetes, Chronic Kidney Disease and Cardiovascular Disease

Journal of the Royal College of Physicians of Edinburgh, The
MedicineEducationHistory
2017English

Economic Impact Associated With Pharmaceutical Interventions in Cardiovascular Disease

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2017English

C-Reactive Protein as a Predictor of Cardiovascular Events in Elderly Patients With Chronic Kidney Disease

Journal of Nephrology
Nephrology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy